Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.
Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.
Golde To Step Down At MSK; Porter Joins Hogan & Hartson.
FASEB Calls For 15% Increase For NIH Next Fiscal Year.
Holden Center At U. Of Iowa Designated Comprehensive.
Obit: George Santos, Hopkins Cancer Treatment Pioneer.
Course On Human Research Protections Goes Online @ Cancer.Gov.
FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.
NCCN Updates Treatment Guidelines To Include CEF For Early Breast Cancer.
US Oncology To Participate In Firm’s Ovarian Cancer Trial.
Atrix, Sanofi In Marketing Deal For Leuprogel Products.
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- George Sigounas named the first-ever chief science advisor at NCI
- A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”
- Makary: Level of evidence is an artificial and dogmatic construct
